|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Operating expenses | ||||
| Operating loss | ||||
| Other non-operating income (expense) | ||||
| Interest income | ||||
| Change in fair value of SAFE Notes | ||||
| Other income | ||||
| Total non-operating expense | ||||
| Net loss | ||||
| Basic weighted average shares outstanding of common stock (in shares) | ||||
| Diluted weighted average shares outstanding of common stock (in shares) | ||||
| Basic net loss per share of common stock (in dollars per share) | ||||
| Diluted net loss per share of common stock (in dollars per share) |
Loading...
